IFNG and neoplasm: Given the dependence of CY+TLRa treatment upon CD4+ and CD8+ T-cells as well as the requirement for IFNγ-producing T-cells for sustained tumor eradication (Figure 2A-2B), we inspected peripheral lymphoid organs for the presence of 4T1-specific T-cells.